Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Permanent URI for this collectionhttps://hdl.handle.net/11147/7148
Browse
2 results
Search Results
Now showing 1 - 2 of 2
Book Part Greenmetric Journey of Izmir Institute of Technology: Agile Strategies Towards a Green Campus(Springer Science and Business Media Deutschland GmbH, 2026) Keskin, E.; Ökten, H.E.; Akpinar, İ.; Baran, Y.Recently, there has been growing attention towards sustainable approaches on university campuses through disseminating international evaluation systems, the UI GreenMetric World University Rankings (GM) attracting specific attention in particular. Türkiye is one of the countries where the number of participating universities in GM rises annually at a significant pace. Most of the large-scale university campuses in Türkiye were already built by the 1990s, which led these campuses to adapt themselves to higher standards for sustainability. In this context, Izmir Institute of Technology (IZTECH), a 33-year-old university, has applied for the GM with its Gülbahçe Campus since 2020. This paper aims to reveal IZTECH’s institutional agile sustainability strategy, energetic and collective processes, and good practices in the last five years while examining the outcomes through the GM’s evaluation of six assessment criteria. In this regard, the sustainability practices of IZTECH have been monitored since 2019 and compared to how the developments have improved the GM scores for the past 3 years. This study, focusing on the IZTECH campus through historical, social, educational, and technological perspectives, unveils the barriers between developing and implementing sustainability practices and examines the cohesion between GM scores and annual reports of campus activities for further projections towards a greener campus. © The Author(s), under exclusive license to Springer Nature Switzerland AG 2026.Article Citation - WoS: 19Citation - Scopus: 20Use of Micrornas in Personalized Medicine(Humana Press Inc., 2014) Avci, C.B.; Baran, Y.Personalized medicine comprises the genetic information together with the phenotypic and environmental factors to yield healthcare tailored to an individual and removes the limitations of the "one-size-fits-all" therapy approach. This provides the opportunity to translate therapies from bench to clinic, to diagnose and predict disease, and to improve patient-tailored treatments based on the unique signatures of a patient's disease and further to identify novel treatment schedules. Nowadays, tiny noncoding RNAs, called microRNAs, have captured the spotlight in molecular biology with highlights like their involvement in DNA translational control, their impression on mRNA and protein expression levels, and their ability to reprogram molecular signaling pathways in cancer. Realizing their pivotal roles in drug resistance, they emerged as diagnostic targets orchestrating drug response in individualized therapy examples. It is not premature to think that researchers could have the US Food and Drug Administration (FDA)-approved kit-based assays for miRNA analysis in the near future. We think that miRNAs are ready for prime time. © Springer Science+Business Media New York 2014.